We are live on ! Find out more
AGIO icon

Agios Pharmaceuticals
AGIO

178 hedge funds and large institutions have $2.69B invested in Agios Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 66 increasing their positions, 58 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 22

14% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 58

4% more funds holding

Funds holding: 171 → 178 (+7)

1.21% more ownership

Funds ownership: 95.18% → 96.38% (+1.2%)

13% less capital invested

Capital invested by funds: $3.07B → $2.69B (-$388M)

33% less call options, than puts

Call options by funds: $10.2M | Put options by funds: $15.1M

80% less funds holding in top 10

Funds holding in top 10: 5 → 1 (-4)

Holders
178
Holders Change
+7
Holders Change %
+4.09%
% of All Funds
4.04%
Holding in Top 10
1
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-80%
% of All Funds
0.02%
New
30
Increased
66
Reduced
58
Closed
22
Calls
$10.2M
Puts
$15.1M
Net Calls
-$4.96M
Net Calls Change
-$9.09M

Top Buyers

1
UBS AM
UBS AM
Illinois
+$19.7M
2
PAMU
Pictet Asset Management (UK)
United Kingdom
+$14.7M
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$14M
4
PI
Putnam Investments
Massachusetts
+$13.3M
5
First Trust Advisors
First Trust Advisors
Illinois
+$10.7M

Top Sellers

1
Capital International Investors
Capital International Investors
California
-$20.5M
2
CI
Capital International
California
-$13.2M
3
QIM
Quantitative Investment Management
Virginia
-$10.3M
4
Invesco
Invesco
Georgia
-$8.69M
5
CWAM
Columbia Wanger Asset Management
Illinois
-$8.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
PIM
76
Platinum Investment Management
Australia
$2.05M – – –
TD Asset Management
77
TD Asset Management
Ontario, Canada
$1.99M +$65.6K +1,043 +3%
JCP
78
Jabre Capital Partners
Switzerland
$1.94M +$2.14M +34,000 New
CS
79
Credit Suisse
Switzerland
$1.94M -$3.47M -55,189 -62%
CIS
80
Capital International Sarl
California
$1.86M -$6.18M -98,200 -75%
CI
81
Capital International
California
$1.84M -$13.2M -209,147 -87%
WIA
82
Wealthstreet Investment Advisors
Texas
$1.84M +$2.02M +32,115 New
MOACM
83
Mutual of America Capital Management
New York
$1.75M +$13.3K +211 +0.7%
UBS Group
84
UBS Group
Switzerland
$1.67M -$1.26M -20,101 -41%
HI
85
Handelsinvest Investeringsforvaltning
Denmark
$1.66M – – –
OPPM
86
Opus Point Partners Management
New York
$1.64M -$292K -4,643 -14%
Group One Trading
87
Group One Trading
Illinois
$1.61M +$325K +5,167 +22%
CII
88
Capital International Inc
California
$1.57M -$834K -13,250 -32%
FIM
89
Fernwood Investment Management
Massachusetts
$1.57M -$18.9K -300 -1%
ProShare Advisors
90
ProShare Advisors
Maryland
$1.57M -$54.1K -860 -3%
ARTA
91
A.R.T. Advisors
New York
$1.5M +$1.66M +26,335 New
GH
92
GAM Holding
Switzerland
$1.38M +$1.52M +24,200 New
Barclays
93
Barclays
United Kingdom
$1.37M -$296K -4,706 -16%
CM
94
Crestline Management
Texas
$1.36M -$333K -5,298 -18%
PPA
95
Parametric Portfolio Associates
Washington
$1.29M +$63.9K +1,015 +5%
AllianceBernstein
96
AllianceBernstein
Tennessee
$1.24M -$765K -12,150 -36%
OC
97
Oppenheimer & Co
New York
$1.15M -$84.7K -1,346 -6%
SGH
98
Sivik Global Healthcare
Connecticut
$1.14M +$1.26M +20,019 New
IBT
99
International Biotechnology Trust
United Kingdom
$1.14M – – –
Ohio Public Employees Retirement System (OPERS)
100
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.02M +$2.71K +43 +0.2%
2 3
4
5 6

AGIO Hedge Fund Activity: Q4 2017 in Review

178 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Agios Pharmaceuticals (AGIO) for Q4 2017, worth a combined $2.69B — down 13% from $3.07B a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new AGIO positions and 22 closed out — a net gain of 8 holders — while 66 added to existing stakes and 58 trimmed.

The largest buyer was UBS AM, adding an estimated $19.7M. The largest seller was Capital International Investors, cutting an estimated $20.5M.

  • 178 institutional investors held Agios Pharmaceuticals (AGIO) as of Q4 2017, up from 171 in Q3 2017.
  • Funds reported $2.69B of Agios Pharmaceuticals stock for Q4 2017, down 13% quarter-over-quarter.
  • 30 funds opened new Agios Pharmaceuticals positions in Q4 2017 and 22 closed out, a net change of +8 holders.
  • The largest Agios Pharmaceuticals buyer in Q4 2017 was UBS AM, an estimated $19.7M added.
  • The largest Agios Pharmaceuticals seller in Q4 2017 was Capital International Investors, an estimated $20.5M sold.

Based on aggregated 13F filings for Q4 2017.